Literature DB >> 10388962

Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.

A I Adler1, E J Boyko, J H Ahroni, D G Smith.   

Abstract

OBJECTIVE: To identify risk factors for lower-extremity amputation (LEA) in individuals with diabetes and to estimate the incidence of LEA. RESEARCH DESIGN AND METHODS: This is a prospective study of 776 U.S. veterans in a general medicine clinic in Seattle, Washington. The outcome was first LEA during follow-up. Potential risk factors evaluated in proportional hazards models included, among others, peripheral vascular disease (PVD), sensory neuropathy, former LEA, foot deformities and ulcers, diabetes duration and treatment, and hyperglycemia.
RESULTS: Associated with an increased risk for LEA were PVD defined as transcutaneous oxygen < or = 50 mmHg (relative risk [RR] = 3.0, 95% CI 1.3-7.1), insensitivity to monofilament testing (RR = 2.9, odds ratio = 1.1-7.8), lower-extremity ulcers (RR = 2.5, CI 1.1-5.4), former LEA, and treatment with insulin when controlling for duration of diabetes and other factors in the model. PVD defined as absent or diminished lower-extremity pulses or an ankle arm index < or = 0.8 was also associated with a significantly higher risk of LEA in separate models. Foot ulcers were associated with an increased ipsilateral risk of amputation. The age-adjusted incidence among men only for LEA standardized to the 1991 U.S. male diabetic population was 11.3/1,000 patient-years.
CONCLUSIONS: This prospective study shows that peripheral sensory neuropathy, PVD, foot ulcers (particularly if they appear on the same side as the eventual LEA), former amputation, and treatment with insulin are independent risk factors for LEA in patients with diabetes.

Entities:  

Mesh:

Year:  1999        PMID: 10388962     DOI: 10.2337/diacare.22.7.1029

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  106 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 3.  Risk factors for diabetic neuropathy and foot ulceration.

Authors:  A Adler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

4.  Initial nontraumatic lower-extremity amputations among veterans with diabetes.

Authors:  Usha Sambamoorthi; Chin-Lin Tseng; Mangala Rajan; Tiwari Anjali; Patricia A Findley; Leonard Pogach
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

5.  A solution to ankle-brachial index limitations in peripheral transluminal angioplasty.

Authors:  Manuel Pardo; Miguel Alcaraz; Fernando Luis Bernal; Jose Manuel Felices; Gyingriri Daniel Achel; Francisco Ramon Breijo-Marquez; Manuel Canteras
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

6.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

7.  Diabetic foot complications in a secondary foot hospital: A clinical audit.

Authors:  Ibrahim Ismail; Ashwini Dhanapathy; Arjun Gandhi; Shanthi Kannan
Journal:  Australas Med J       Date:  2015-04-30

Review 8.  The epidemiology of neuropathic foot ulcers in individuals with diabetes.

Authors:  Jay Sosenko
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

10.  Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Authors:  J Dawn Abbott; Manuel S Lombardero; Gregory W Barsness; Ivan Pena-Sing; L Virginia Buitrón; Premranjan Singh; Gail Woodhead; Jean-Claude Tardif; Sheryl F Kelsey
Journal:  Am Heart J       Date:  2012-10       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.